Cargando…
The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center Study
Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is present worldwide. Autoantibodies, in particular anti-mitochondrial antibodies (AMA) detected by indirect immunofluorescence assays or newer solid phase immunoassays can detect most, but not all individuals with PBC....
Autores principales: | Norman, Gary L., Reig, Anna, Viñas, Odette, Mahler, Michael, Wunsch, Ewa, Milkiewicz, Piotr, Swain, Mark G., Mason, Andrew, Stinton, Laura M., Aparicio, Maria Belen, Aldegunde, Maria Jose, Fritzler, Marvin J., Parés, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456688/ https://www.ncbi.nlm.nih.gov/pubmed/31001269 http://dx.doi.org/10.3389/fimmu.2019.00662 |
Ejemplares similares
-
PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC)
por: Stinton, Laura M., et al.
Publicado: (2014) -
Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis
por: Wasik, Urszula, et al.
Publicado: (2020) -
Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis
por: Wunsch, Ewa, et al.
Publicado: (2020) -
A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunity
por: Nguyen, Henry H., et al.
Publicado: (2018) -
Detection of M2-Type Anti-Mitochondrial Autoantibodies against Specific Subunits in the Diagnosis of Primary Biliary Cholangitis in Patients with Discordant Results
por: Arnaldos-Pérez, Cristina, et al.
Publicado: (2023)